Latest news

Better outcomes for head and neck cancers treated at Providence Cancer Center
A recent retrospective study finds a 96 percent two-year survival for people with advanced head and neck cancers treated at Providence with intensity modulated radiation therapy (IMRT). These outcomes far exceed historical averages, which range between 30 to 60 percent.
Hope for young patients with Hodgkin's lymphoma and non-Hodgkin's lymphoma
Research into more effective therapies at Providence Cancer Center is paying off with very high quality survivorship and long life for many patients diagnosed with lymphoma, according to Lymphoma Program medical director Craig Nichols, M.D.
Subscribe to our Wellness Watch e-Newsletter
Expert advice on a variety of health topics arrives in your inbox every month when you subscribe to “Wellness Watch,” Providence’s e-Newsletter. Each issue features Providence physicians and medical staff offering helpful information on topics such as heart health, fitness, pregnancy and nutrition, as well as details about upcoming classes, community events, and much more. Subscribe today.










